Quantum-Si (NASDAQ:QSI) CFO Jeffry Keyes Sells 37,381 Shares of Stock

Quantum-Si Incorporated (NASDAQ:QSI) CFO Jeffry Keyes sold 37,381 shares of the stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total value of $37,007.19. Following the completion of the transaction, the chief financial officer owned 1,732,582 shares of the company’s stock, valued at $1,715,256.18. This represents a 2.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Quantum-Si Trading Up 8.5%

Quantum-Si stock opened at $1.06 on Thursday. The company has a market capitalization of $229.35 million, a PE ratio of -2.04 and a beta of 3.08. Quantum-Si Incorporated has a 12 month low of $0.69 and a 12 month high of $3.10. The stock has a 50-day moving average price of $0.90 and a two-hundred day moving average price of $1.28.

Quantum-Si (NASDAQ:QSI) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%. As a group, analysts predict that Quantum-Si Incorporated will post -0.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

A number of hedge funds have recently modified their holdings of the business. Wealth Management Associates Inc. lifted its holdings in shares of Quantum-Si by 14.8% during the third quarter. Wealth Management Associates Inc. now owns 30,950 shares of the company’s stock worth $44,000 after purchasing an additional 4,000 shares during the period. SBI Securities Co. Ltd. boosted its holdings in Quantum-Si by 28.6% in the third quarter. SBI Securities Co. Ltd. now owns 33,616 shares of the company’s stock valued at $47,000 after acquiring an additional 7,475 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Quantum-Si by 15.6% in the second quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock valued at $131,000 after acquiring an additional 9,005 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Quantum-Si by 30.8% in the third quarter. SG Americas Securities LLC now owns 42,107 shares of the company’s stock valued at $59,000 after acquiring an additional 9,926 shares during the last quarter. Finally, Hollencrest Capital Management boosted its holdings in Quantum-Si by 40.0% in the third quarter. Hollencrest Capital Management now owns 35,000 shares of the company’s stock valued at $49,000 after acquiring an additional 10,000 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Wall Street Analysts Forecast Growth

QSI has been the subject of several research reports. Canaccord Genuity Group dropped their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $3.25.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.